LISA GEBHART: Open Payments
NPI 1376090779 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 7 payments from 7 companies in 2025. Trend: 2023 $276 · 2024 $245 · 2025 $446
Food & beverage: $276Education: $170
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $92 |
| Astellas Pharma US Inc | 1 | $91 |
| Ipsen Biopharmaceuticals, Inc | 1 | $78 |
| Iovance Biotherapeutics, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $20 |
| Caris MPI, Inc. | 1 | $18 |
Products named: Trodelvy, ERLEADA, Vyloy, Amtagvi, XT CDX, MI CANCER SEEK.
Industry payments across OH — which companies pay providers there.
